In the News January 15, 2016

Bloomberg BNA | Outlook 2016: Drug Prices, User Fees, Biosimilars Among Key Topics

Cathy Burgess is quoted on the Food and Drug Administration’s continued focus on inspecting outsourcing facilities for pharmacy compounding and the promotion of cGMP requirements.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement